Establishment Labs Extends NuSil Supply Agreement Through 2031
Establishment Labs signed a supply agreement amendment with NuSil Technology through wholly owned subsidiary ELSA on October 14, 2026. The amendment extends the initial term from December 31, 2026, to December 31, 2031, effective January 1, 2027. The agreement covers NuSil's manufacture and sale of medical-grade silico